http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23068356

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Journal Article
endingPage 1044
issn 0007-0920
1532-1827
issueIdentifier 6
pageRange 1038-1044
publicationName British Journal of Cancer
startingPage 1038
bibliographicCitation Franceschi E, Cavallo G, Scopece L, Paioli A, Pession A, Magrini E, Conforti R, Palmerini E, Bartolini S, Rimondini S, Esposti RD, Crinò L. Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. British Journal of Cancer. 2004 Aug 10;91(6):1038–44. doi: 10.1038/sj.bjc.6602105.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8edbc1f497f17378af12b5cdffa718de
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5336b87592a5dab40ed9d5f0dcd7ab05
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d33faa9c22b34479e442a06a50dc3c4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ca9cad153c52e32a467bda922432130
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d240b358b50901f5364d1c5ff975791
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6195489329e5fca84fb3fef222125a8a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_409c63fedeed7cd97e6239b61e4e99c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bab30c03a4f84cc76bccc17701b6c22
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ac86ccce3025b8d94587e23c94cc553
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f61b578cbe17d74c9d03202c611c2be
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44ed3dad7a3bd578d6364a62d34807f5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea078b73684f0ea0f7b10566873c5c77
date 2004-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2747702
https://pubmed.ncbi.nlm.nih.gov/15305187
https://doi.org/10.1038/sj.bjc.6602105
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/1532-1827
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma
discusses http://id.nlm.nih.gov/mesh/M0007930
http://id.nlm.nih.gov/mesh/M0001435
http://id.nlm.nih.gov/mesh/M0006678
http://id.nlm.nih.gov/mesh/M0024707
http://id.nlm.nih.gov/mesh/M0381050
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918763
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6988
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7839
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7838
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128856490
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127548128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127986152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128482492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127676247

Total number of triples: 56.